Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2024-10-09 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of securities for the quarter ended 30th September 2024. It is a compliance certificate from the Registrar and Share Transfer Agent to the stock exchanges and the company. The document is short (3112 characters) and primarily serves as a certification or confirmation letter rather than containing financial data or detailed report content. According to the Certification Rule, such officer certifications or compliance confirmations should be classified as Regulatory Filings (RNS).
2024-10-09 English
As per attachment
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of securities for the quarter ended 30th September 2024. It is a compliance certificate from the Registrar and Share Transfer Agent to the stock exchanges and the company. The document is short (3112 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is also not an announcement of a report publication but a certificate confirming regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and confirmations.
2024-10-09 English
Board Meeting — LYKA LABS LIMITED has informed the Exchange about Board Meeting to be held on 11-Oct-2024 to consider Amalgamation.
Regulatory Filings
2024-10-04 English
Board Meeting — Other business matters
Board/Management Information Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the filing of a fresh application for the amalgamation of a subsidiary with the company. It references compliance with SEBI Listing Obligations and Disclosure Requirements, Regulation 29, which pertains to disclosures about board meetings. The document is a short notice informing the stock exchanges about the upcoming board meeting and its agenda. It does not contain financial data, audit information, or detailed reports. It is not a full report but an announcement related to board management activities. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1744 characters), consistent with a meeting notice rather than a full report.
2024-10-04 English
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/10/2024 ,inter alia, to consider and approve As per attachment
Board/Management Information Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the filing of a fresh application for the amalgamation of a subsidiary with the company. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures related to board meetings. The document is a formal announcement about an upcoming board decision related to corporate restructuring (amalgamation). It does not contain financial data, audit information, or detailed report content. It is not a full report, earnings release, or proxy solicitation. The content fits best under Board/Management Information (MANG) as it announces a board meeting and its agenda regarding corporate action.
2024-10-04 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. It mentions the closure period is from 30th September 2024 until 48 hours after the declaration of unaudited financial results for the quarter and half year ended 30th September 2024. The letter is signed by the Managing Director & CEO. The document does not contain any financial data or results itself, nor does it announce the results. It is an announcement related to insider trading compliance and trading restrictions ahead of financial results disclosure. The document length is short (1688 characters), and it is clearly an announcement rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-09-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.